| Renee Wright, | |
|
200 1st St Sw, Rochester, MN 55905-0001 | |
| (507) 284-2511 | |
| Not Available |
| Full Name | Renee Wright |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 200 1st St Sw, Rochester, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679948244 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 103949 (Minnesota) | Primary |
| Provider Name | Mayo Clinic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
New research released at the Society of Interventional Radiology's (SIR) Annual Scientific Meeting in Washington, D.C., this week, holds promise of a new interventional imaging capability using advanced robotics provided by Siemens Healthcare (www.siemens.com/healthcare), to improve the value of chemoembolization in treating cancer.
Nationwide, nurse workloads have increased due to higher patient acuity, increased documentation requirements and shortages of staff. Today's nurse finds it more difficult to manage the multiple demands of patients, families and other members of the healthcare team. Put simply, nurses frequently lack the time to do what they joined the profession to do - provide quality patient care.
A Cancer Research UK initiative to improve cancer gene testing has prompted two pharmaceutical companies to plan pioneering international trials into targeted cancer treatments in the UK.
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Renee Wright, 200 1st St Sw, Rochester, MN 55905-0001 Ph: () - | Renee Wright, 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 |
News Archive
New research released at the Society of Interventional Radiology's (SIR) Annual Scientific Meeting in Washington, D.C., this week, holds promise of a new interventional imaging capability using advanced robotics provided by Siemens Healthcare (www.siemens.com/healthcare), to improve the value of chemoembolization in treating cancer.
Nationwide, nurse workloads have increased due to higher patient acuity, increased documentation requirements and shortages of staff. Today's nurse finds it more difficult to manage the multiple demands of patients, families and other members of the healthcare team. Put simply, nurses frequently lack the time to do what they joined the profession to do - provide quality patient care.
A Cancer Research UK initiative to improve cancer gene testing has prompted two pharmaceutical companies to plan pioneering international trials into targeted cancer treatments in the UK.
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.
› Verified 5 days ago
Amy L Krekelberg, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Danielle Anshus, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Erika Hope Mckeever, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Deborah Engen, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Susan D Hansen, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Mary B Clark, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Sara Kathleen Tallman, O.T.D. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |